GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AMED Co Ltd (ROCO:7575) » Definitions » Capex-to-Operating-Income

AMED Co (ROCO:7575) Capex-to-Operating-Income : 0.25 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is AMED Co Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

AMED Co's Capital Expenditure for the six months ended in Dec. 2023 was NT$-18.22 Mil. Its Operating Income for the six months ended in Dec. 2023 was NT$71.97 Mil.

Hence, AMED Co's Capex-to-Operating-Income for the six months ended in Dec. 2023 was 0.25.


AMED Co Capex-to-Operating-Income Historical Data

The historical data trend for AMED Co's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AMED Co Capex-to-Operating-Income Chart

AMED Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
0.72 0.22 0.91 0.33 0.24

AMED Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only 0.11 0.41 0.28 0.23 0.25

Competitive Comparison of AMED Co's Capex-to-Operating-Income

For the Medical Instruments & Supplies subindustry, AMED Co's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AMED Co's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AMED Co's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where AMED Co's Capex-to-Operating-Income falls into.



AMED Co Capex-to-Operating-Income Calculation

AMED Co's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-30.138) / 123.401
=0.24

AMED Co's Capex-to-Operating-Income for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-18.224) / 71.968
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AMED Co  (ROCO:7575) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


AMED Co Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of AMED Co's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


AMED Co (ROCO:7575) Business Description

Traded in Other Exchanges
N/A
Address
No. 14, Wuquan 7th Road, 4th Floor, Wugu District, New Taipei, TWN
AMED Co Ltd is fully committed to the research and development of UV photopolymerized hydrogels. It is a professional research and development and manufacturing company of wound dressing materials, providing proper wound care solutions, and marketing the product under the brand of Heli Dressing.

AMED Co (ROCO:7575) Headlines

No Headlines